Circular RNA aptamers ameliorate AD-relevant phenotypes by targeting PKR

Xin Feng,Bo-Wen Jiang,Si-Nan Zhai,Chu-Xiao Liu,Hao Wu,Bang-Qi Zhu,Meng-Yuan Wei,Jia Wei,Li Yang,Ling-Ling Chen
DOI: https://doi.org/10.1101/2024.03.27.583257
2024-03-27
Abstract:Here, we delineated the remarkably elevated neuroinflammation accompanied by progressive activation of double-stranded RNA (dsRNA)-activated Protein Kinase R (PKR) and PKR-related dsRNA pathways in hippocampus of 5×FAD mice upon Alzheimer’s disease (AD) progression. AAV-delivery of circular RNAs possessing short-imperfect duplex regions (ds-cRNAs) to neurons and microglia effectively dampened excessive PKR activity with little toxicity, accompanying with reduced neuroinflammation and amyloid-beta (Aβ) plaques, resulting in neuroprotection and enhanced capability of spatial learning and memory in AD mouse models. These findings suggest a therapeutic potential of ds-cRNA aptamers as PKR inhibitors in AD therapy.
Molecular Biology
What problem does this paper attempt to address?